BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bio-Rad Laboratories, Inc. (BIO)'s New CFX Qualification Plate Offers Reliable Performance Verification on Any CFX Real-Time PCR System


12/7/2012 11:57:08 AM

Hercules, CA — December 6, 2012 — Bio-Rad Laboratories, Inc. today announced the launch of the CFX qualification plate, an easy-to-use tool for accurately verifying the performance of any CFX real-time PCR system, providing researchers with confidence in their results.

Preloaded with an optimized master mix containing Bio-Rad’s SsoAdvanced™ SYBR® Green supermix, the CFX qualification plate provides a five-point standard curve, two unknown groups, and no-template controls, allowing for the rapid determination of a pass/fail instrument performance result.

Included in Bio-Rad’s CFX Manager™ software is the new qualification plate check tool for analyzing the CFX qualification plate data. The tool uses an algorithm to determine a pass/fail performance result based on two criteria: twofold discrimination with a 99.7% confidence level and single-product melt peaks for the two unknowns. A passing result indicates good optical performance and uniform thermal block control.

The CFX qualification plate joins Bio-Rad’s new PCR instrument validation tools for verifying Bio-Rad’s real-time PCR detection systems.

For more information about the CFX qualification plate, please visit http://www.bio-rad.com/cfxqualification.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The Company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs over 7,100 people globally and had revenues exceeding $2 billion in 2011. For more information, visit www.bio-rad.com.

For more information contact:

Rachel Scott

Bio-Rad

510-741-6336

Rachel Scott@bio-rad.com

Ken Li

Chempetitive Group

312-997-2436 x 112

kli@chempetitive.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES